| 1 | optimal | 12,232 |
| 2 | optimum | 1,858 |
| 3 | ultra-low | 47 |
| 4 | maximum-tolerated | 34 |
| 5 | ultralow | 30 |
| 6 | otoprotective | 13 |
| 7 | anisotonic | 9 |
| 8 | isoeffective | 7 |
| 9 | ncep-recommended | 7 |
| 10 | patient-managed | 6 |
| 11 | sublingual-swallow | 5 |
| 12 | unoptimized | 5 |
| 13 | 3d-xy | 4 |
| 14 | 50-micrograms | 4 |
| 15 | 6gy | 4 |
| 16 | equipotential | 4 |
| 17 | near-neutral | 4 |
| 18 | orqis | 4 |
| 19 | post-mv | 4 |
| 20 | 800-mcg | 3 |
| 21 | envelope-based | 3 |
| 22 | erlotinib-first | 3 |
| 23 | extra-familial | 3 |
| 24 | ffr-based | 3 |
| 25 | follicular-phase | 3 |
| 26 | high-iodine | 3 |
| 27 | hypocholesteremic | 3 |
| 28 | in-advance | 3 |
| 29 | isotoxic | 3 |
| 30 | patient-individualized | 3 |
| 31 | tai-2 | 3 |
| 32 | 100-mg/d | 2 |
| 33 | 7.5μg | 2 |
| 34 | ada-recommended | 2 |
| 35 | adalimumab-plus-mtx-initiated | 2 |
| 36 | annulo-ventricular | 2 |
| 37 | antiinitiation/promotion | 2 |
| 38 | beamlet | 2 |
| 39 | dacca | 2 |
| 40 | ha'emek | 2 |
| 41 | html/cgi | 2 |
| 42 | keto-enamine | 2 |
| 43 | maximum-allowable | 2 |
| 44 | mesostructural | 2 |
| 45 | miv-miv | 2 |
| 46 | posthypothermic | 2 |
| 47 | regenstrief | 2 |
| 48 | seating-induced | 2 |
| 49 | st-rule | 2 |
| 50 | tau-spectral | 2 |
| 51 | unaerated | 2 |
| 52 | ventriculo-annular | 2 |
| 53 | -0,16 | 1 |
| 54 | 2-g/d | 1 |
| 55 | 3d-ising | 1 |
| 56 | 40-60mg/day | 1 |
| 57 | 81st | 1 |
| 58 | acelullar | 1 |
| 59 | acid-to-neutral | 1 |
| 60 | anxioloytics/sedatives/hypnotics | 1 |
| 61 | barzilai | 1 |
| 62 | biomonitored | 1 |
| 63 | chung-shan | 1 |
| 64 | colinox | 1 |
| 65 | computer-expedited | 1 |
| 66 | computerassisted | 1 |
| 67 | conventional/delayed | 1 |
| 68 | di-enol-dione | 1 |
| 69 | egton | 1 |
| 70 | engrafting | 1 |
| 71 | equi-antinociceptive | 1 |
| 72 | ex-lab | 1 |
| 73 | finnish-norwegian | 1 |
| 74 | hallam | 1 |
| 75 | heat-stimulation | 1 |
| 76 | hiv-targeted | 1 |
| 77 | hypnosis/control | 1 |
| 78 | ichor | 1 |
| 79 | ideg-flex-group | 1 |
| 80 | indi-vidual | 1 |
| 81 | individually-optimized | 1 |
| 82 | infection.the | 1 |
| 83 | keto-amine | 1 |
| 84 | king/drew | 1 |
| 85 | low-pl | 1 |
| 86 | maimonides | 1 |
| 87 | meander | 1 |
| 88 | microencapsules | 1 |
| 89 | mvj | 1 |
| 90 | máxima | 1 |
| 91 | nbutanol | 1 |
| 92 | ncep-based | 1 |
| 93 | newly-founded | 1 |
| 94 | normal-abnormal | 1 |
| 95 | oasis™ | 1 |
| 96 | oticon | 1 |
| 97 | paitilla | 1 |
| 98 | palm-leaf | 1 |
| 99 | prehospital/emergency | 1 |
| 100 | products׳ | 1 |
| 101 | radiologist-rated | 1 |
| 102 | rdt-oriented | 1 |
| 103 | skeletotopic | 1 |
| 104 | state-running | 1 |
| 105 | subtoxicity | 1 |
| 106 | tanadug | 1 |
| 107 | tareev | 1 |
| 108 | tele-airway | 1 |
| 109 | thione-thiol | 1 |
| 110 | tmsc-based | 1 |
| 111 | transvaginal/perineal | 1 |
| 112 | urosurgical | 1 |
| 113 | user-selected | 1 |
| 114 | weight-guided | 1 |
| 1 | -0,16 | 1 |
| 2 | 100-mg/d | 2 |
| 3 | 2-g/d | 1 |
| 4 | 3d-ising | 1 |
| 5 | 3d-xy | 4 |
| 6 | 40-60mg/day | 1 |
| 7 | 50-micrograms | 4 |
| 8 | 6gy | 4 |
| 9 | 7.5μg | 2 |
| 10 | 800-mcg | 3 |
| 11 | 81st | 1 |
| 12 | acelullar | 1 |
| 13 | acid-to-neutral | 1 |
| 14 | ada-recommended | 2 |
| 15 | adalimumab-plus-mtx-initiated | 2 |
| 16 | anisotonic | 9 |
| 17 | annulo-ventricular | 2 |
| 18 | antiinitiation/promotion | 2 |
| 19 | anxioloytics/sedatives/hypnotics | 1 |
| 20 | barzilai | 1 |
| 21 | beamlet | 2 |
| 22 | biomonitored | 1 |
| 23 | chung-shan | 1 |
| 24 | colinox | 1 |
| 25 | computer-expedited | 1 |
| 26 | computerassisted | 1 |
| 27 | conventional/delayed | 1 |
| 28 | dacca | 2 |
| 29 | di-enol-dione | 1 |
| 30 | egton | 1 |
| 31 | engrafting | 1 |
| 32 | envelope-based | 3 |
| 33 | equi-antinociceptive | 1 |
| 34 | equipotential | 4 |
| 35 | erlotinib-first | 3 |
| 36 | ex-lab | 1 |
| 37 | extra-familial | 3 |
| 38 | ffr-based | 3 |
| 39 | finnish-norwegian | 1 |
| 40 | follicular-phase | 3 |
| 41 | ha'emek | 2 |
| 42 | hallam | 1 |
| 43 | heat-stimulation | 1 |
| 44 | high-iodine | 3 |
| 45 | hiv-targeted | 1 |
| 46 | html/cgi | 2 |
| 47 | hypnosis/control | 1 |
| 48 | hypocholesteremic | 3 |
| 49 | ichor | 1 |
| 50 | ideg-flex-group | 1 |
| 51 | in-advance | 3 |
| 52 | indi-vidual | 1 |
| 53 | individually-optimized | 1 |
| 54 | infection.the | 1 |
| 55 | isoeffective | 7 |
| 56 | isotoxic | 3 |
| 57 | keto-amine | 1 |
| 58 | keto-enamine | 2 |
| 59 | king/drew | 1 |
| 60 | low-pl | 1 |
| 61 | maimonides | 1 |
| 62 | maximum-allowable | 2 |
| 63 | maximum-tolerated | 34 |
| 64 | meander | 1 |
| 65 | mesostructural | 2 |
| 66 | microencapsules | 1 |
| 67 | miv-miv | 2 |
| 68 | mvj | 1 |
| 69 | máxima | 1 |
| 70 | nbutanol | 1 |
| 71 | ncep-based | 1 |
| 72 | ncep-recommended | 7 |
| 73 | near-neutral | 4 |
| 74 | newly-founded | 1 |
| 75 | normal-abnormal | 1 |
| 76 | oasis™ | 1 |
| 77 | optimal | 12,232 |
| 78 | optimum | 1,858 |
| 79 | orqis | 4 |
| 80 | oticon | 1 |
| 81 | otoprotective | 13 |
| 82 | paitilla | 1 |
| 83 | palm-leaf | 1 |
| 84 | patient-individualized | 3 |
| 85 | patient-managed | 6 |
| 86 | post-mv | 4 |
| 87 | posthypothermic | 2 |
| 88 | prehospital/emergency | 1 |
| 89 | products׳ | 1 |
| 90 | radiologist-rated | 1 |
| 91 | rdt-oriented | 1 |
| 92 | regenstrief | 2 |
| 93 | seating-induced | 2 |
| 94 | skeletotopic | 1 |
| 95 | st-rule | 2 |
| 96 | state-running | 1 |
| 97 | sublingual-swallow | 5 |
| 98 | subtoxicity | 1 |
| 99 | tai-2 | 3 |
| 100 | tanadug | 1 |
| 101 | tareev | 1 |
| 102 | tau-spectral | 2 |
| 103 | tele-airway | 1 |
| 104 | thione-thiol | 1 |
| 105 | tmsc-based | 1 |
| 106 | transvaginal/perineal | 1 |
| 107 | ultra-low | 47 |
| 108 | ultralow | 30 |
| 109 | unaerated | 2 |
| 110 | unoptimized | 5 |
| 111 | urosurgical | 1 |
| 112 | user-selected | 1 |
| 113 | ventriculo-annular | 2 |
| 114 | weight-guided | 1 |
| 1 | tai-2 | 3 |
| 2 | -0,16 | 1 |
| 3 | dacca | 2 |
| 4 | paitilla | 1 |
| 5 | máxima | 1 |
| 6 | ex-lab | 1 |
| 7 | hypocholesteremic | 3 |
| 8 | posthypothermic | 2 |
| 9 | anisotonic | 9 |
| 10 | skeletotopic | 1 |
| 11 | isotoxic | 3 |
| 12 | 2-g/d | 1 |
| 13 | 100-mg/d | 2 |
| 14 | seating-induced | 2 |
| 15 | weight-guided | 1 |
| 16 | ada-recommended | 2 |
| 17 | ncep-recommended | 7 |
| 18 | newly-founded | 1 |
| 19 | patient-managed | 6 |
| 20 | biomonitored | 1 |
| 21 | tmsc-based | 1 |
| 22 | envelope-based | 3 |
| 23 | ncep-based | 1 |
| 24 | ffr-based | 3 |
| 25 | adalimumab-plus-mtx-initiated | 2 |
| 26 | radiologist-rated | 1 |
| 27 | unaerated | 2 |
| 28 | maximum-tolerated | 34 |
| 29 | user-selected | 1 |
| 30 | hiv-targeted | 1 |
| 31 | computer-expedited | 1 |
| 32 | rdt-oriented | 1 |
| 33 | computerassisted | 1 |
| 34 | conventional/delayed | 1 |
| 35 | patient-individualized | 3 |
| 36 | individually-optimized | 1 |
| 37 | unoptimized | 5 |
| 38 | in-advance | 3 |
| 39 | infection.the | 1 |
| 40 | maximum-allowable | 2 |
| 41 | st-rule | 2 |
| 42 | high-iodine | 3 |
| 43 | keto-amine | 1 |
| 44 | keto-enamine | 2 |
| 45 | di-enol-dione | 1 |
| 46 | follicular-phase | 3 |
| 47 | isoeffective | 7 |
| 48 | otoprotective | 13 |
| 49 | equi-antinociceptive | 1 |
| 50 | palm-leaf | 1 |
| 51 | regenstrief | 2 |
| 52 | 800-mcg | 3 |
| 53 | state-running | 1 |
| 54 | 3d-ising | 1 |
| 55 | engrafting | 1 |
| 56 | tanadug | 1 |
| 57 | 7.5μg | 2 |
| 58 | barzilai | 1 |
| 59 | html/cgi | 2 |
| 60 | mvj | 1 |
| 61 | ha'emek | 2 |
| 62 | urosurgical | 1 |
| 63 | transvaginal/perineal | 1 |
| 64 | extra-familial | 3 |
| 65 | equipotential | 4 |
| 66 | optimal | 12,232 |
| 67 | normal-abnormal | 1 |
| 68 | tau-spectral | 2 |
| 69 | acid-to-neutral | 1 |
| 70 | near-neutral | 4 |
| 71 | mesostructural | 2 |
| 72 | indi-vidual | 1 |
| 73 | thione-thiol | 1 |
| 74 | nbutanol | 1 |
| 75 | hypnosis/control | 1 |
| 76 | low-pl | 1 |
| 77 | hallam | 1 |
| 78 | optimum | 1,858 |
| 79 | chung-shan | 1 |
| 80 | finnish-norwegian | 1 |
| 81 | oticon | 1 |
| 82 | heat-stimulation | 1 |
| 83 | antiinitiation/promotion | 2 |
| 84 | egton | 1 |
| 85 | ideg-flex-group | 1 |
| 86 | acelullar | 1 |
| 87 | annulo-ventricular | 2 |
| 88 | ventriculo-annular | 2 |
| 89 | meander | 1 |
| 90 | ichor | 1 |
| 91 | anxioloytics/sedatives/hypnotics | 1 |
| 92 | maimonides | 1 |
| 93 | microencapsules | 1 |
| 94 | orqis | 4 |
| 95 | 50-micrograms | 4 |
| 96 | beamlet | 2 |
| 97 | 81st | 1 |
| 98 | erlotinib-first | 3 |
| 99 | tareev | 1 |
| 100 | miv-miv | 2 |
| 101 | post-mv | 4 |
| 102 | king/drew | 1 |
| 103 | ultra-low | 47 |
| 104 | ultralow | 30 |
| 105 | sublingual-swallow | 5 |
| 106 | colinox | 1 |
| 107 | 40-60mg/day | 1 |
| 108 | tele-airway | 1 |
| 109 | prehospital/emergency | 1 |
| 110 | 6gy | 4 |
| 111 | subtoxicity | 1 |
| 112 | 3d-xy | 4 |
| 113 | oasis™ | 1 |
| 114 | products׳ | 1 |